Lead sponsor
Morten Hostrup, PhD
2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of November 5, 2026.
2
Trials led
2
Ongoing
82
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Not applicable
2
Trials by status
Not yet recruiting
2
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Short Term Effects of Semaglutide on Body Composition and PerformanceBMI 21-26not applicableNot yet recruiting41
Long-Term Effects of Semaglutide on Body Composition and Performance in RunningBMI 21-26not applicableNot yet recruiting41